Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy-Reference-Cited by-同舟云学术

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Published:2004-01 Issue:2 Volume:40 Page:205-211
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Petit T.,Wilt M.,Velten M.,Millon R.,Rodier J.-F.,Borel C.,Mors R.,Haegelé P.,Eber M.,Ghnassia J.-P.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. The role of clinical response;Pierga;Eur. J. Cancer,2003

2. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer;Chollet;Br. J. Cancer,2002

3. HER2;Piccart;Eur. J. Cancer,2000

4. When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer;Yamauchi;J. Clin. Oncol.,2001

5. DNA topoisomerase poisons as anti-tumor drugs;Liu;Ann. Rev. Biochem.,1989

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the Predictive Role of Ki-67 in Breast Cancer Patients’ Responses to Neoadjuvant Chemotherapy;European Journal of Breast Health;2024-07-01

2. Neoadjuvant Chemotherapy in Patients with HER2-Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran;Archives of Iranian Medicine;2024-04-01

3. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients;Diagnostic Pathology;2024-03-20

4. A Novel Machine Learning Approach for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: Integration of Multimodal Radiomics With Clinical and Molecular Subtype Markers;IEEE Access;2024

5. Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer;International Journal of Biological Macromolecules;2023-12